Basel Medical
BMGL
9 hedge funds and large institutions have $70.2K invested in Basel Medical in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.07% less ownership
Funds ownership: 0.13% → 0.06% (-0.07%)
10% less funds holding
Funds holding: 10 → 9 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
87% less capital invested
Capital invested by funds: $525K → $70.2K (-$454K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$41.5K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$37.4K |
| 3 |
Jane Street
New York
|
+$20K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$18.8K |
| 5 |
Renaissance Technologies
New York
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$135K |
| 2 |
MG
Marex Group
London,
|
-$105K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$84.1K |
| 4 |
VF
Virtu Financial
New York
|
-$61K |
| 5 |
Vanguard Personalized Indexing Management
Oakland,
California
|
-$40.2K |
BMGL Hedge Fund Activity: Q4 2025 in Review
9 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Basel Medical (BMGL) for Q4 2025, worth a combined $70.2K — down 87% from $525K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BMGL and 5 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Ground Swell Capital, opening a new position worth an estimated $41.5K. The largest seller was Morgan Stanley, exiting entirely with an estimated $135K sold.
- 9 institutional investors held Basel Medical (BMGL) as of Q4 2025, down from 10 in Q3 2025.
- Funds reported $70.2K of Basel Medical stock for Q4 2025, down 87% quarter-over-quarter.
- 5 funds opened new Basel Medical positions in Q4 2025 and 6 closed out, a net change of -1 holder.
- The largest Basel Medical buyer in Q4 2025 was Ground Swell Capital, an estimated $41.5K added.
- The largest Basel Medical seller in Q4 2025 was Morgan Stanley, an estimated $135K sold.
Based on aggregated 13F filings for Q4 2025.